Fasting boosts breast cancer therapy efficacy via glucocorticoid activation
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 85 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Breast cancerThis series is part of our curated briefing on it.
- Samples
- 85 samples: 24 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Fasting boosts breast cancer therapy efficacy via glucocorticoid activationNature · 2026
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE260486_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1081869 and SRA study SRP492378. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 81 samples.
How we read this: 24 replicated groups read from 85 sample titles; they account for 81 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8118158 MCF7_Control_ER_Rep1 MCF7_Control_ER
- GSM8118159 MCF7_Control_ER_Rep2 MCF7_Control_ER
- GSM8118160 MCF7_Control_ER_Rep3 MCF7_Control_ER
- GSM8118161 MCF7_TMX_ER_Rep1 MCF7_TMX_ER
- GSM8118162 MCF7_TMX_ER_Rep2 MCF7_TMX_ER
- GSM8118163 MCF7_TMX_ER_Rep3 MCF7_TMX_ER
- GSM8118164 MCF7_Fasting_ER_Rep1 MCF7_Fasting_ER
- GSM8118165 MCF7_Fasting_ER_Rep2 MCF7_Fasting_ER
- GSM8118166 MCF7_Fasting_ER_Rep3 MCF7_Fasting_ER
- GSM8118167 MCF7_TMXplusFasting_ER_Rep1 MCF7_TMXplusFasting_ER
- GSM8118168 MCF7_TMXplusFasting_ER_Rep2 MCF7_TMXplusFasting_ER
- GSM8118169 MCF7_TMXplusFasting_ER_Rep3 MCF7_TMXplusFasting_ER
- GSM8118170 MCF7_TMXplusFasting_ER_Rep4 MCF7_TMXplusFasting_ER
- GSM8118171 MCF7_TMXplusFasting_ER_Rep5 MCF7_TMXplusFasting_ER
- GSM8118172 MCF7_TMXplusFasting_ER_Rep6 MCF7_TMXplusFasting_ER
- GSM8118173 MCF7_Control_H3K27ac_Rep1 MCF7_Control_H3K27ac
- GSM8118174 MCF7_Control_H3K27ac_Rep2 MCF7_Control_H3K27ac
- GSM8118175 MCF7_Control_H3K27ac_Rep3 MCF7_Control_H3K27ac
- GSM8118176 MCF7_TMX_H3K27ac_Rep1 MCF7_TMX_H3K27ac
- GSM8118177 MCF7_TMX_H3K27ac_Rep2 MCF7_TMX_H3K27ac
- GSM8118178 MCF7_TMX_H3K27ac_Rep3 MCF7_TMX_H3K27ac
- GSM8118179 MCF7_Fasting_H3K27ac_Rep1 MCF7_Fasting_H3K27ac
- GSM8118180 MCF7_Fasting_H3K27ac_Rep2 MCF7_Fasting_H3K27ac
- GSM8118181 MCF7_Fasting_H3K27ac_Rep3 MCF7_Fasting_H3K27ac
- GSM8118182 MCF7_TMXplusFasting_H3K27ac_Rep1 MCF7_TMXplusFasting_H3K…
- GSM8118183 MCF7_TMXplusFasting_H3K27ac_Rep2 MCF7_TMXplusFasting_H3K…
- GSM8118184 MCF7_TMXplusFasting_H3K27ac_Rep3 MCF7_TMXplusFasting_H3K…
- GSM8118185 MCF7_TMXplusFasting_H3K27ac_Rep4 MCF7_TMXplusFasting_H3K…
- GSM8118186 MCF7_TMXplusFasting_H3K27ac_Rep5 MCF7_TMXplusFasting_H3K…
- GSM8118187 MCF7_TMXplusFasting_H3K27ac_Rep6 MCF7_TMXplusFasting_H3K…
- GSM8118188 MCF7_Control_GR_Rep1 MCF7_Control_GR
- GSM8118189 MCF7_Control_GR_Rep2 MCF7_Control_GR
- GSM8118190 MCF7_Control_GR_Rep3 MCF7_Control_GR
- GSM8118191 MCF7_TMX_GR_Rep1 MCF7_TMX_GR
- GSM8118192 MCF7_TMX_GR_Rep2 MCF7_TMX_GR
- GSM8118193 MCF7_TMX_GR_Rep3 MCF7_TMX_GR
- GSM8118194 MCF7_Fasting_GR_Rep1 MCF7_Fasting_GR
- GSM8118195 MCF7_Fasting_GR_Rep2 MCF7_Fasting_GR
- GSM8118196 MCF7_Fasting_GR_Rep3 MCF7_Fasting_GR
- GSM8118197 MCF7_TMXplusFasting_GR_Rep1 MCF7_TMXplusFasting_GR
+ 45 more — browse all 85 samples with per-sample file links →
- GSE104193 Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signalling and malignant features in vitro and in vivo 32 samples same disease briefing · shares activation, breast
- GSE10886 A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 226 samples same disease briefing · shares breast
- GSE11121 The humoral immune system has a key prognostic impact in node-negative breast cancer 200 samples same disease briefing · shares breast
- GSE104675 Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6 samples same disease briefing · shares breast
- GSE10885 An integromic analysis reveals that metaplastic carcinomas are distinct from basal-like tumors. 244 samples same disease briefing
- GSE211434 Diverse immune suppressing cancer communications with myeloid cells prevent T cell activation and recruitment and provide resistance to cell cycle inhibitor therapy 81 samples shares activation, therapy
- GSE279219 Early downmodulation of tumor glycolysis predicts response to fasting-mimicking diet in triple-negative breast cancer patients 24 samples shares fasting, breast
- GSE235244 Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma suppress CD8+ T cell activation and inhibit response to immune checkpoint therapy [hPDAC] 8 samples shares activation, therapy
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.